Cocrystal Pharma (COCP) Intangibles (2011 - 2013)
Cocrystal Pharma (COCP) posted Intangibles of $162616.0 for Q2 2013, down 8.0% sequentially from $176755.0 in Q1 2013, and down 25.8% YoY from $219172.0 in Q2 2012.
Cocrystal Pharma (COCP) Intangibles (2011 - 2013) Analysis & Trends
Cocrystal Pharma has reported Intangibles for 3 years, with the latest figure at $162616.0 in Q2 2013.
- Quarterly Intangibles fell 25.8% year-over-year to $162616.0 in Q2 2013, while the trailing twelve-month figure through Jun 2013 was $162616.0 (down 25.8% YoY) and the FY2012 annual result came in at $190894.0, down 22.86% from the prior year.
- Intangibles declined to $162616.0 in Q2 2013 per COCP's latest filing, from $176755.0 in the prior quarter.
- Over five years, Intangibles peaked at $247450.0 in Q4 2011 and troughed at $162616.0 in Q2 2013.
- A 3-year average of $205033.0 and a median of $205033.0 in 2012 frame the typical range for Intangibles.
- The sharpest annual moves came in 2012 and 2013: Intangibles fell 22.86% in 2012, then slipped 25.8% in 2013.
- Over 3 years, Intangibles stood at $247450.0 in 2011, then declined by 22.86% to $190894.0 in 2012, then retreated by 14.81% to $162616.0 in 2013.
- According to Business Quant data, Intangibles over the past three periods registered $162616.0, $176755.0, and $190894.0 for Q2 2013, Q1 2013, and Q4 2012 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 162,616.00 |
| Mar 31, 2013 | 176,755.00 |
| Dec 31, 2012 | 190,894.00 |
| Sep 30, 2012 | 205,033.00 |
| Jun 30, 2012 | 219,172.00 |
| Mar 31, 2012 | 233,311.00 |
| Dec 31, 2011 | 247,450.00 |